{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:52:20Z","timestamp":1790013140924,"version":"4.0.1"},"reference-count":30,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0401","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T22:11:19Z","timestamp":1729635079000},"page":"103-113","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves\u2019 disease"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-6647","authenticated-orcid":false,"given":"Nami","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7340-8603","authenticated-orcid":false,"given":"Jaeduk","family":"Yoshimura Noh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-320X","authenticated-orcid":false,"given":"Ai","family":"Kozaki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Olympia Eye Hospital, Tokyo 150-0001, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5004","authenticated-orcid":false,"given":"Natsuko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1323-4722","authenticated-orcid":false,"given":"Ai","family":"Yoshihara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-5891","authenticated-orcid":false,"given":"Miho","family":"Fukushita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9641-0991","authenticated-orcid":false,"given":"Hideyuki","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Hiruma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-5342","authenticated-orcid":false,"given":"Masahiro","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0170-2804","authenticated-orcid":false,"given":"Masakazu","family":"Koshibu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sankoda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2998-7656","authenticated-orcid":false,"given":"Rei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5443-4020","authenticated-orcid":false,"given":"Toshu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Olympia Eye Hospital, Tokyo 150-0001, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-9871","authenticated-orcid":false,"given":"Kiminori","family":"Sugino","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, et al. (2017) 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid 27: 315\u2013389.","DOI":"10.1089\/thy.2016.0457"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, et al. (2016) 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 26: 1343\u20131421.","DOI":"10.1089\/thy.2016.0229"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Peng CC, Pearce EN (2022) An update on thyroid disorders in the postpartum period. J Endocrinol Invest 45: 1497\u20131506.","DOI":"10.1007\/s40618-022-01762-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kahaly GJ, Bartalena L, Hegedus L, Leenhardt L, Poppe K, et al. (2018) 2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism. Eur Thyroid J 7: 167\u2013186.","DOI":"10.1159\/000490384"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Bucci I, Giuliani C, Napolitano G (2017) Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne) 8: 137.","DOI":"10.3389\/fendo.2017.00137"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ford HF, Spies A (2001) Postpartum proptosis with ophthalmopathy. Optom Vis Sci 78: 75\u201378.","DOI":"10.1097\/00006324-200102000-00006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Gilbert AL, Prasad S, Mallery RM (2019) Neuro-ophthalmic disorders in pregnancy. Neurol Clin 37: 85\u2013102.","DOI":"10.1016\/j.ncl.2018.09.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Wall JR, Lahooti H, Hibbert EJ, Champion B (2015) Relationship between clinical and immunological features of thyroid autoimmunity and ophthalmopathy during pregnancy. J Thyroid Res 2015: 698470.","DOI":"10.1155\/2015\/698470"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Stafford IP, Dildy GA 3rd, Miller JM Jr (2005) Severe Graves\u2019 ophthalmopathy in pregnancy. Obstet Gynecol 105: 1221\u20131223.","DOI":"10.1097\/01.AOG.0000157759.40119.f9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Aranyosi JK, Deli T, Erdei A, Toth G, Jakab A, et al. (2020) Unusual onset of thyroid associated orbitopathy during pregnancy: case report and review of literature. BMC Endocr Disord 20: 183.","DOI":"10.1186\/s12902-020-00663-9"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sakurai K, Inoue T, Niitsuma S, Sato R, Takahashi K, et al. (2020) Sight-threatening Graves\u2019 ophthalmopathy during the third trimester of pregnancy: a case report. Tohoku J Exp Med 252: 321\u2013327.","DOI":"10.1620\/tjem.252.321"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Koshibu M, Watanabe N, Suzuki N, Takahashi Y, Onda H, et al. (2024) Exacerbation of thyroid eye disease and dysthyroid optic neuropathy during pregnancy: a case report. Intern Med doi: 10.2169\/internalmedicine.3872-24. Online ahead of print.","DOI":"10.2169\/internalmedicine.3872-24"},{"key":"13","unstructured":"13 The Japan Thyroid Association, The Japan Endocrine Society  (2023) Management of thyroid eye disease; a statement by the Japan Thyroid Association and the Japan Endocrine Society 2023 (the 3rd edition):19. https:\/\/www.j-endo.jp\/uploads\/files\/edu\/koujyousengansyo_3.pdf accessed on September 16, 2024 (in Japanese)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Tachibana S, Murakami T, Noguchi H, Noguchi Y, Nakashima A, et al. (2010) Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves\u2019 ophthalmopathy. Endocr J 57: 853\u2013861.","DOI":"10.1507\/endocrj.K10E-156"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Chng CL, Seah LL, Khoo DH (2012) Ethnic differences in the clinical presentation of Graves\u2019 ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26: 249\u2013258.","DOI":"10.1016\/j.beem.2011.10.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Zhang H, Fan J, Qu J, Han Q, Zhou H, et al. (2023) Predictive markers for anti-inflammatory treatment response in thyroid eye disease. Front Endocrinol (Lausanne) 14: 1292519.","DOI":"10.3389\/fendo.2023.1292519"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, et al. (2022) Management of thyroid eye disease: a consensus statement by the american thyroid association and the european thyroid association. Thyroid 32: 1439\u20131470.","DOI":"10.1089\/thy.2022.0251"},{"key":"18","first-page":"36","volume":"6","author":"FF Rundle","year":"1957","unstructured":"18 Rundle FF (1957) Management of exophthalmos and related ocular changes in Graves\u2019 disease. Metabolism 6: 36\u201348.","journal-title":"Metabolism Clinical and Experimental","ISSN":"https:\/\/id.crossref.org\/issn\/0026-0495","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Suzuki N, Noh JY, Yoshimura R, Mikura K, Kinoshita A, et al. (2021) Does age or sex relate to severity or treatment prognosis in Graves\u2019 disease? Thyroid 31: 1409\u20131415.","DOI":"10.1089\/thy.2020.0881"},{"key":"20","unstructured":"20 Kamijo K, Maruyama H, Togashi K (2014) Fundamental and clinical studies on modified bioassay for TSAb using porcine thyroid cells. Japanese Journal of Medicine and Pharmaceutical Science 71: 903\u2013911 (in Japanese)."},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, et al. (2000) Thyroid-stimulating antibody is related to Graves\u2019 ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves\u2019 disease. Thyroid 10: 809\u2013813.","DOI":"10.1089\/thy.2000.10.809"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Miller D, Gershater M, Slutsky R, Romero R, Gomez-Lopez N (2020) Maternal and fetal T cells in term pregnancy and preterm labor. Cell Mol Immunol 17: 693\u2013704.","DOI":"10.1038\/s41423-020-0471-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Amino N, Arata N (2020) Thyroid dysfunction following pregnancy and implications for breastfeeding. Best Pract Res Clin Endocrinol Metab 34: 101438.","DOI":"10.1016\/j.beem.2020.101438"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, et al. (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91: 3464\u20133470.","DOI":"10.1210\/jc.2005-2813"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Watanabe N, Yoshimura Noh J, Kozaki A, Yoshimura R, Yoshihara A, et al. (2023) Incidence and risk factors for Graves\u2019 orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves\u2019 disease: investigation of 1,553 cases with newly diagnosed Graves\u2019 disease and proposal of a predictive score. Endocr J 70: 1087\u20131096.","DOI":"10.1507\/endocrj.EJ23-0079"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Bartalena L, Gallo D, Tanda ML, Kahaly GJ (2023) Thyroid eye disease: epidemiology, natural history, and risk factors. Ophthalmic Plast Reconstr Surg 39: S2\u2013S8.","DOI":"10.1097\/IOP.0000000000002467"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, et al. (2022) Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association. Eur Thyroid J 11: e220189.","DOI":"10.1530\/ETJ-22-0189"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, et al. (1990) Effect of abnormal thyroid function on the severity of Graves\u2019 ophthalmopathy. Arch Intern Med 150: 1098\u20131101.","DOI":"10.1001\/archinte.150.5.1098"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, et al. (2020) Characteristics of patients with Graves\u2019 disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy. Thyroid 30: 451\u2013456.","DOI":"10.1089\/thy.2019.0392"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30 Sato S, Noh JY, Sato S, Suzuki M, Yasuda S, et al. (2015) Comparison of efficacy and adverse effects between methimazole 15 mg + inorganic iodine 38 mg\/day and methimazole 30 mg\/day as initial therapy for Graves\u2019 disease patients with moderate to severe hyperthyroidism. Thyroid 25: 43\u201350.","DOI":"10.1089\/thy.2014.0084"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0401\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T03:35:22Z","timestamp":1736566522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0401\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0401","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0401"}}